Translational insights on developmental origins of metabolic syndrome: Focus on fructose consumption

Biomed J. 2018 Apr;41(2):96-101. doi: 10.1016/j.bj.2018.02.006.

Abstract

Metabolic syndrome (MetS) is a highly prevalent complex trait despite recent advances in pathophysiology and pharmacological treatment. MetS can begin in early life by so-called the developmental origins of health and disease (DOHaD). The DOHaD concept offers a novel approach to prevent MetS through reprogramming. High fructose (HF) intake has been associated with increased risk of MetS. HF diet becomes one of the most commonly used animal model to induce MetS. This review discusses the maternal HF diet induced programming process and reprogramming strategy to prevent MetS of developmental origin, with an emphasis on: (1) an overview of metabolic effects of fructose consumption on MetS; (2) insight from maternal HF animal models on MetS-related phenotypes; (3) impact of HF consumption induces organ-specific transcriptome changes; and (4) application of reprogramming strategy to prevent maternal HF consumption-induced MetS. Research into the preventions and treatments of MetS that begin early in life will have a lifelong impact and profound savings in disease burden and financial costs.

Keywords: Developmental origins of health and disease (DOHaD); Fructose; Hypertension; Metabolic syndrome; Obesity.

Publication types

  • Review

MeSH terms

  • Animals
  • Dietary Carbohydrates / adverse effects
  • Disease Models, Animal
  • Female
  • Fructose / adverse effects*
  • Fructose / metabolism
  • Humans
  • Metabolic Syndrome / etiology*
  • Metabolic Syndrome / prevention & control
  • Metabolic Syndrome / therapy
  • Pregnancy
  • Transcriptome

Substances

  • Dietary Carbohydrates
  • Fructose